Literature DB >> 24412968

Associations of Age, Gender, and Subtypes With ADHD Symptoms and Related Comorbidity in a Danish Sample of Clinically Referred Adults.

Helle Moeller Soendergaard1, Per Hove Thomsen2, Erik Pedersen3, Pernille Pedersen4, Agnethe Elkjaer Poulsen3, Lars Winther3, Jette Moeskjaer Nielsen3, Anne Henriksen3, Berit Rungoe4, Hans Joergen Soegaard4.   

Abstract

OBJECTIVE: The aim was to examine associations of age and gender with ADHD subtypes and subsequently to examine associations of age, gender, and subtypes with comorbid psychiatric disorders.
METHOD: Odds ratios were calculated and logistic regression performed using information from a clinical sample of 155 ADHD adults referred to a Danish specialized ADHD unit from 2010 to 2011.
RESULTS: A majority of men (65%) was found in the sample. Most patients were subtyped ADHD combined (78%), followed by ADHD inattentive (18%), and ADHD hyperactive-impulsive (4%). No significant differences were found in gender and age across subtypes. Current comorbid disorders were found in 57% of the ADHD patients. Significantly more comorbidity was found in the ADHD combined type and in patients ≥25 years. Significantly more men had substance use disorders and significantly more women had personality disorders.
CONCLUSION: When assessing adult ADHD patients' age, gender, subtype, and related comorbid symptom profiles should be taken into account.
© The Author(s) 2014.

Entities:  

Keywords:  adult ADHD; age; comorbidity; gender; psychiatric outpatients

Mesh:

Year:  2014        PMID: 24412968     DOI: 10.1177/1087054713517544

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  8 in total

Review 1.  Comorbidity of Personality Disorders and Adult Attention Deficit Hyperactivity Disorder (ADHD)--Review of Recent Findings.

Authors:  Swantje Matthies; Alexandra Philipsen
Journal:  Curr Psychiatry Rep       Date:  2016-04       Impact factor: 5.285

2.  Adults With Persistent ADHD: Gender and Psychiatric Comorbidities-A Population-Based Longitudinal Study.

Authors:  Kouichi Yoshimasu; William J Barbaresi; Robert C Colligan; Robert G Voigt; Jill M Killian; Amy L Weaver; Slavica K Katusic
Journal:  J Atten Disord       Date:  2016-11-18       Impact factor: 3.256

3.  Attention Deficit Hyperactivity Disorder (ADHD) Subtypes, Co-Occurring Psychiatric Symptoms and Sexual Risk Behaviors among Adolescents Receiving Substance Abuse Treatment.

Authors:  Timothy Regan; Jonathan Tubman
Journal:  Subst Use Misuse       Date:  2019-09-10       Impact factor: 2.164

4.  Psychiatric comorbid patterns in adults with attention-deficit hyperactivity disorder: Treatment effect and subtypes.

Authors:  Fang-Ju Tsai; Wan-Ling Tseng; Li-Kuang Yang; Susan Shur-Fen Gau
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

5.  The Characteristics of Mood Polarity, Temperament, and Suicide Risk in Adult ADHD.

Authors:  Giancarlo Giupponi; Marco Innamorati; Elena Rogante; Salvatore Sarubbi; Denise Erbuto; Ignazio Maniscalco; Livia Sanna; Andreas Conca; David Lester; Maurizio Pompili
Journal:  Int J Environ Res Public Health       Date:  2020-04-21       Impact factor: 3.390

6.  Psychopathologic Profiles and Clusters in Tertiary Clinic Referred Patients with Adult Attention Deficit Hyperactivity Disorder: A Person-Centered Analysis.

Authors:  Yunhye Oh; Hyewon Park; Seonwoo Kim; Hye Seung Kim; Yoo-Sook Joung; Kyung Sue Hong; Ji Hyun Baek
Journal:  Psychiatry Investig       Date:  2021-04-25       Impact factor: 2.505

7.  Adult ADHD screening scores and hospitalization due to pedestrian injuries: a case-control study.

Authors:  Alireza Sadeghpour; Homayoun Sadeghi-Bazargani; Saber Ghaffari-Fam; Shaker Salarilak; Mostafa Farahbakhsh; Robert Ekman; Amin Daemi
Journal:  BMC Psychiatry       Date:  2020-09-10       Impact factor: 3.630

Review 8.  ADHD and Bipolar Disorder in Adulthood: Clinical and Treatment Implications.

Authors:  Virginio Salvi; Enrico Ribuoli; Michele Servasi; Laura Orsolini; Umberto Volpe
Journal:  Medicina (Kaunas)       Date:  2021-05-10       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.